Cargando…
Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
Type 2 diabetes (T2D) is a leading cause of death and disability worldwide. It is a chronic metabolic disorder that develops due to an interplay of genetic, lifestyle, and environmental factors. The biological onset of the disease occurs long before clinical symptoms develop, thus the search for ear...
Autores principales: | Willmer, Tarryn, Johnson, Rabia, Louw, Johan, Pheiffer, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288427/ https://www.ncbi.nlm.nih.gov/pubmed/30564199 http://dx.doi.org/10.3389/fendo.2018.00744 |
Ejemplares similares
-
Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
por: Willmer, Tarryn, et al.
Publicado: (2019) -
DNA methylation of FKBP5 in South African women: associations with obesity and insulin resistance
por: Willmer, Tarryn, et al.
Publicado: (2020) -
Ethnic and Adipose Depot Specific Associations Between DNA Methylation and Metabolic Risk
por: Pheiffer, Carmen, et al.
Publicado: (2020) -
The role of maternal DNA methylation in pregnancies complicated by gestational diabetes
por: Dias, Stephanie, et al.
Publicado: (2022) -
Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development
por: Riedel, Sylvia, et al.
Publicado: (2022)